Tag: Homework Solution

  • [Solved] week 2 DB response 2

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    see attachment – a year ago **files (1)** – ## Week2DBresponse2-.pdf **## Week2DBresponse2-.pdf** Table 1 Infection Description Presentation Causes/ Risk Factors Treatment per CDC Addtl info Candida Fungal infection due to candida albicans Pruritic, soreness, dyspareunia , occasionally thick vaginal…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    see attachment

    – a year ago

    **files (1)**

    – ## Week2DBresponse2-.pdf

    **## Week2DBresponse2-.pdf**

    Table 1

    Infection Description Presentation Causes/ Risk
    Factors

    Treatment per
    CDC

    Addtl
    info

    Candida

    Fungal
    infection due
    to candida
    albicans

    Pruritic,
    soreness,
    dyspareunia
    ,
    occasionally
    thick
    vaginal
    discharge
    and dysuria.
    KOH
    demonstrate
    s budding

    Pregnancy,
    immunosupression,
    antibiotic use,
    diabetes

    – Fluconazole 150
    mg single dose

    Not
    usually
    considere
    d an STI.

    BV

    Vaginal
    discharge or
    malodorous in
    childbearing
    people. N

    Mal-
    odorous/
    fishy odor,
    thin gray-
    white
    discharge,
    clue cells on

    sexual activity,
    particularly with
    new or multiple
    partners, the use of
    douching, and not
    using condoms

    Metronidazole 500
    mg BID x 7 days
    OR 0.75% gel x 5
    days

    Not
    sexually
    transmittt
    ed

    Chlamydi
    a

    STI caused by
    Chlamydia
    trachomatis

    Often
    Asymptoma
    tic;
    cervicitis,
    urethritis,
    dysuria,
    postcoital
    bleeding

    having multiple or
    new sexual
    partners, not using
    condoms during
    sex, and having a
    history of other
    STIs

    Doxycycline 100
    mg BID x 7 days
    (preferred); or
    Azithromycin 1 g
    PO x1

    Sexually
    transmitt
    ed;
    screen
    annually

    Gonorrhe
    a

    STI caused by
    Nisseria
    gonorrheae

    Purulent
    discharge,
    pelvic pain,
    dysuria,
    urethritis,
    often
    asymptomat
    ic in women

    unprotected sex,
    having multiple
    sexual partners, a
    history of other
    sexually
    transmitted
    infections (STIs),
    and being a young
    adult (under 25)

    Ceftriaxone 500
    mg IM x1 (if <150
    kg); treat
    Chlamydia
    empirically unless
    ruled out

    Sexually
    transmitt
    ed,
    screen
    annually

    Trichomo
    nas

    STI caused by
    Trichomonas
    vaginalis

    Frothy
    yellow-
    green
    discharge,
    strawberry
    cervix, foul
    odor,

    Multiple partners,
    unprotected sex

    Metronidazole 500
    mg BID x 7 days
    or 2g PO x1

    Sexually
    transmitt
    ed,
    partner
    needs to
    be
    treated

    Cervicitis
    Inflammation
    of cervix due
    to STI

    Mucopurule
    nt
    discharge,
    cervical
    bleeding
    with contact

    Chlamydia,
    Gonorrhea, HSV

    Treat based on
    organism;
    empirically cover
    Chlamydia &
    Gonorrhea

    Can
    cause
    PID if
    not
    treater

    PID

    Ascending
    polymicrobial
    infection of
    upper genital
    tract

    Pelvic pain,
    cervical
    motion
    tenderness,
    fever,
    discharge

    Untreated
    Chlamydia/
    Gonorrhea,
    multiple partners

    Ceftriaxone 500
    mg IM x1 +
    Doxycycline 100
    mg BID x 14d

    Metronidazole

    Risk for
    infertility

    HIV

    Human
    immunodeficie
    ncy virus , a
    virus that
    attacks cells
    that help the
    body fight
    infection.
    Affects the

    Acute: flu-
    like
    symptoms

    Chronic:
    becomes
    opportunisti
    c infection

    Unprotected sex,
    IV drug use, MSM,
    mother-to-child

    ART
    (Antiretroviral
    therapy) – lifelong

    Screenin
    g should
    be
    offered
    annually

    Syphilis
    STI caused by
    treponema
    pallidum

    Primary:
    Painless
    chancre

    Secondary:
    rash on
    palms, soles

    Tertiary:
    neurological
    and cardiac
    involvement

    MSM, HIV+,
    multiple partners,
    unprotected sex

    Benzathine
    penicillin G 2.4M
    units IM x1
    (early); weekly x3
    (late/unknown
    duration)

    Screen
    all
    pregnant
    patients,
    treat
    partners.

    Table 2

    Hep B

    hepatitis B
    virus is a small
    DNA virus that
    belongs to the
    “Hepadnavirid
    ae” family.

    Fatigue,
    jaundice,
    RUQ pain

    Sexual contact, IV
    drug use, perinatal
    transmission,
    healthcare
    exposure

    Supportive care
    (acute); Antivirals
    for chronic (e.g.,
    tenofovir,
    entecavir)

    Screenin
    g done to
    all
    pregnant
    patients,
    vaccine
    available

    Hep C

    Hepatitis C is a
    viral infection
    that causes
    liver swelling,
    called
    inflammation.
    Hepatitis C can
    lead to serious
    liver damage.

    Faituge,
    jaundice

    IV drug use, blood
    transfusions
    (pre-1992), sexual
    exposure

    Direct-acting
    antivirals (e.g.,
    sofosbuvir/
    velpatasvir) for 8–
    12 weeks

    Screen
    adults, no
    vaccine
    available

    HSV

    Herpes
    Simplex Virus.
    Herpes is a
    common virus
    that can cause
    cold sores or
    genital sores. It
    spreads
    through skin-
    to-skin contact

    Painless
    vesciles or
    ulcers,
    dysuria,
    systemic
    symptoms
    during
    primary
    infection

    Oral/genital
    contact,
    unprotected sex,
    vertical
    transmission

    Acyclovir 400 mg
    TID x 7–10 days
    or Valacyclovir 1g
    BID x 7–10 days

    Lifelong
    therapy

    Question Answer

    Name 10 Risk Factors for contracting STI’s
    and HIV

    1. Having unprotected sex

    2. Having multiple partners

    3. Injection of drugs with dirty needle
    sharing.

    4. History of previous STI

    5. Substance use

    6. Sex work or transactional sex

    7. Lac of access to healthcare or education

    8. Not being vaccinated against preventable
    STIs

    9. Being incarcerated or having a partner
    who is

    10.Sexual coercion or violence

    Name 5 safer sex practices

    1. Limiting sexual partners

    2. Regular STI testing, especially with new
    partners

    3. Use condoms every tine you have sex

    4. Avoid sex under the influence of drugs or
    alcohol

    5. Inspect partners for visible sore or
    symptoms

    Can HIV be transmitted through sweat, saliva,
    and tears? (Include rationale)

    No, HIV can be transmitted from one infected
    person to another through blood, semen,
    vaginal secretions, rectal fluids and breast
    milk. For HIV to occur, the HIV in these fluids
    must get into the bloodstream of an HIV-
    negative person through a mucous membrane
    through open cuts or sores, or by direct
    injection.

    Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
    week after having unprotected vaginal intercourse with a new male partner she has been dating
    for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
    health care provider, you will need to perform testing to determine if Lisa has contracted a
    sexually transmitted infection or other vaginal infection.

    SOAP NOTE

    Demographic: 19/ Female G0P0

    Subjective

    Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
    intercourse with a new male partner that I have been dating for a couple of weeks.”

    Name 2 types of intercourse are at the highest
    risk for contracting HIV

    1. Unprotected vaginal sex

    2. Unprotected anal sex

    Why are women more susceptible to HIV in a
    male to female relationship (versus a male
    contracting it from a female)?

    In women, several factors can increase the risk
    of HIV transmission. For example, during
    vaginal or anal intercourse, women are at
    greater risk of acquiring HIV because
    receptive sex is generally riskier than insertive
    sex. Age-related thinning and dryness of the
    vaginal tissue—common in older women—
    can lead to microtears during intercourse,
    providing a pathway for HIV transmission.
    Biologically, women are more vulnerable to
    infection due to the larger mucosal surface
    area exposed during penile penetration.
    Additionally, young women under the age of
    17 are at even higher risk because they have
    an underdeveloped cervix and produce less
    protective vaginal mucus.

    HPI:

    Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
    after having unprotected vaginal intercourse with a new male partner.

    • Onset: one week
    • Locating: vaginal
    • Duration: ongoing
    • Characteristic: abnormal
    • Aggrevating/relieving factors: none stated
    • Treatment: none tried

    HPI questions:

    • Is there any vaginal itching, burning or odor?
    • Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
    • Have you had this type of discharge in the past?
    • When was the last time you were tested for STIs?

    Gyn history:

    • LMP: 2 weeks ago, stated, regular
    • Unknown if on birth control at this time
    • Sexually active, new male partner, no protection
    • No known gynocological issues at this time.

    Medical history

    • No known medical conditions
    • No known surgical conditions
    • No known drug allergies
    • Immunizations: up to date

    Family history:

    • Mother: no known medical history
    • Father: no known medical history
    • Maternal grandmother: no known medical history
    • Paternal grandmother: no known medical history,

    Social history

    • Goes to school

    • Balanced diet
    • Regular exercise
    • No drug or alcohol use
    • Sexual history: one new male partner, no protection
    • Relationship: new

    Other questions

    • Are you in a monogamous relationship?
    • Do you practice safe sex?

    Review of systems:

    • General: healthy, denies fever denies chills
    • Neuro: denies headacces or dizziness
    • Cardiovascular: denies chest pain or palpitations
    • Resp: denies shortness of breaeth or cough
    • GI: denies nausea, vomiting or diarrhea or abdominal pain
    • GU: positive abnormal discharge
    • Skin: denies rash, denies new lesions
    • Health maintenance: No Pap in the last 12 months due to age

    Objective

    Vitals: WNL

    • Temp: 98.6
    • BP: 120/80
    • HR:78
    • RR: 17
    • Heihgt: 5’4”
    • Weight: 135
    • BMI: 23.2

    Physical exam:

    • General: AAOx4, no acute distress
    • abdomen soft, non tender
    • Pelvic:

    o Vulva: normal appearance
    o Vagina: abnormal discharge
    o Cervix: normal
    o Uterus: non tender
    o Adnexa: no masses or tenderness

    POCT

    • Urine pregnancy : negative
    o Rule out pregnancy due to age and no condom use
    • Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
    o KOH to help identify yeast, or bv or trichomonas cells
    • NAAT
    o For STI screening

    Assessment

    Final diagnosis:

    • Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

    Differential:

    • Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
    • Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
    • Chlamydia A56.0 – due to new sexual partner after unprotected sex

    Plan

    Diagnostics:

    • NAAT: Chlamydia, Gonorrhea and trichomonas
    • KOH for BV
    • Serology for HIV, syphilis, Hep B and C
    • Pap smear

    Treatments:

    • Fluconazole 150 mg Po x 1 dose orally

    o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
    candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
    medication should not be prescribed if patient has a history of liver disease.

    If STI positive: depending on what STI patient comes back positive for, prescriptions will
    change. Both patient and partner will need to be treated and abstain from sex for a week.

    Patient education:

    • Risk factors for STIs
    • Abstain from sex for 7 days until symptoms have resolved, and medication taken
    • Practice safe sex
    • Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
    • Routine STI screening

    Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
    partner and increased risk for HIV and other STIs.

    Referals: refer to GYN follow up

    Follow up;

    • Office will call when lab results return
    • Follow up in one week if symptoms do not improve
    • Pap smear

    Health maintenance:

    • Pap smear starting at age 21
    • Hpv vaccine
    • STI screening annualy or whena new partner
    • Up to date on vaccines

    **## Week2DBresponse2-.pdf**

    Table 1

    Infection Description Presentation Causes/ Risk
    Factors

    Treatment per
    CDC

    Addtl
    info

    Candida

    Fungal
    infection due
    to candida
    albicans

    Pruritic,
    soreness,
    dyspareunia
    ,
    occasionally
    thick
    vaginal
    discharge
    and dysuria.
    KOH
    demonstrate
    s budding

    Pregnancy,
    immunosupression,
    antibiotic use,
    diabetes

    – Fluconazole 150
    mg single dose

    Not
    usually
    considere
    d an STI.

    BV

    Vaginal
    discharge or
    malodorous in
    childbearing
    people. N

    Mal-
    odorous/
    fishy odor,
    thin gray-
    white
    discharge,
    clue cells on

    sexual activity,
    particularly with
    new or multiple
    partners, the use of
    douching, and not
    using condoms

    Metronidazole 500
    mg BID x 7 days
    OR 0.75% gel x 5
    days

    Not
    sexually
    transmittt
    ed

    Chlamydi
    a

    STI caused by
    Chlamydia
    trachomatis

    Often
    Asymptoma
    tic;
    cervicitis,
    urethritis,
    dysuria,
    postcoital
    bleeding

    having multiple or
    new sexual
    partners, not using
    condoms during
    sex, and having a
    history of other
    STIs

    Doxycycline 100
    mg BID x 7 days
    (preferred); or
    Azithromycin 1 g
    PO x1

    Sexually
    transmitt
    ed;
    screen
    annually

    Gonorrhe
    a

    STI caused by
    Nisseria
    gonorrheae

    Purulent
    discharge,
    pelvic pain,
    dysuria,
    urethritis,
    often
    asymptomat
    ic in women

    unprotected sex,
    having multiple
    sexual partners, a
    history of other
    sexually
    transmitted
    infections (STIs),
    and being a young
    adult (under 25)

    Ceftriaxone 500
    mg IM x1 (if <150
    kg); treat
    Chlamydia
    empirically unless
    ruled out

    Sexually
    transmitt
    ed,
    screen
    annually

    Trichomo
    nas

    STI caused by
    Trichomonas
    vaginalis

    Frothy
    yellow-
    green
    discharge,
    strawberry
    cervix, foul
    odor,

    Multiple partners,
    unprotected sex

    Metronidazole 500
    mg BID x 7 days
    or 2g PO x1

    Sexually
    transmitt
    ed,
    partner
    needs to
    be
    treated

    Cervicitis
    Inflammation
    of cervix due
    to STI

    Mucopurule
    nt
    discharge,
    cervical
    bleeding
    with contact

    Chlamydia,
    Gonorrhea, HSV

    Treat based on
    organism;
    empirically cover
    Chlamydia &
    Gonorrhea

    Can
    cause
    PID if
    not
    treater

    PID

    Ascending
    polymicrobial
    infection of
    upper genital
    tract

    Pelvic pain,
    cervical
    motion
    tenderness,
    fever,
    discharge

    Untreated
    Chlamydia/
    Gonorrhea,
    multiple partners

    Ceftriaxone 500
    mg IM x1 +
    Doxycycline 100
    mg BID x 14d

    Metronidazole

    Risk for
    infertility

    HIV

    Human
    immunodeficie
    ncy virus , a
    virus that
    attacks cells
    that help the
    body fight
    infection.
    Affects the

    Acute: flu-
    like
    symptoms

    Chronic:
    becomes
    opportunisti
    c infection

    Unprotected sex,
    IV drug use, MSM,
    mother-to-child

    ART
    (Antiretroviral
    therapy) – lifelong

    Screenin
    g should
    be
    offered
    annually

    Syphilis
    STI caused by
    treponema
    pallidum

    Primary:
    Painless
    chancre

    Secondary:
    rash on
    palms, soles

    Tertiary:
    neurological
    and cardiac
    involvement

    MSM, HIV+,
    multiple partners,
    unprotected sex

    Benzathine
    penicillin G 2.4M
    units IM x1
    (early); weekly x3
    (late/unknown
    duration)

    Screen
    all
    pregnant
    patients,
    treat
    partners.

    Table 2

    Hep B

    hepatitis B
    virus is a small
    DNA virus that
    belongs to the
    “Hepadnavirid
    ae” family.

    Fatigue,
    jaundice,
    RUQ pain

    Sexual contact, IV
    drug use, perinatal
    transmission,
    healthcare
    exposure

    Supportive care
    (acute); Antivirals
    for chronic (e.g.,
    tenofovir,
    entecavir)

    Screenin
    g done to
    all
    pregnant
    patients,
    vaccine
    available

    Hep C

    Hepatitis C is a
    viral infection
    that causes
    liver swelling,
    called
    inflammation.
    Hepatitis C can
    lead to serious
    liver damage.

    Faituge,
    jaundice

    IV drug use, blood
    transfusions
    (pre-1992), sexual
    exposure

    Direct-acting
    antivirals (e.g.,
    sofosbuvir/
    velpatasvir) for 8–
    12 weeks

    Screen
    adults, no
    vaccine
    available

    HSV

    Herpes
    Simplex Virus.
    Herpes is a
    common virus
    that can cause
    cold sores or
    genital sores. It
    spreads
    through skin-
    to-skin contact

    Painless
    vesciles or
    ulcers,
    dysuria,
    systemic
    symptoms
    during
    primary
    infection

    Oral/genital
    contact,
    unprotected sex,
    vertical
    transmission

    Acyclovir 400 mg
    TID x 7–10 days
    or Valacyclovir 1g
    BID x 7–10 days

    Lifelong
    therapy

    Question Answer

    Name 10 Risk Factors for contracting STI’s
    and HIV

    1. Having unprotected sex

    2. Having multiple partners

    3. Injection of drugs with dirty needle
    sharing.

    4. History of previous STI

    5. Substance use

    6. Sex work or transactional sex

    7. Lac of access to healthcare or education

    8. Not being vaccinated against preventable
    STIs

    9. Being incarcerated or having a partner
    who is

    10.Sexual coercion or violence

    Name 5 safer sex practices

    1. Limiting sexual partners

    2. Regular STI testing, especially with new
    partners

    3. Use condoms every tine you have sex

    4. Avoid sex under the influence of drugs or
    alcohol

    5. Inspect partners for visible sore or
    symptoms

    Can HIV be transmitted through sweat, saliva,
    and tears? (Include rationale)

    No, HIV can be transmitted from one infected
    person to another through blood, semen,
    vaginal secretions, rectal fluids and breast
    milk. For HIV to occur, the HIV in these fluids
    must get into the bloodstream of an HIV-
    negative person through a mucous membrane
    through open cuts or sores, or by direct
    injection.

    Lisa is a 19-year-old female who presents to the clinic c/o abnormal vaginal discharge for one
    week after having unprotected vaginal intercourse with a new male partner she has been dating
    for a couple of weeks. Lisa’s pregnancy test is negative and her LMP was 2 weeks ago. As her
    health care provider, you will need to perform testing to determine if Lisa has contracted a
    sexually transmitted infection or other vaginal infection.

    SOAP NOTE

    Demographic: 19/ Female G0P0

    Subjective

    Chief complain: “abnormal vaginal discharge for one week after having unprotected vaginal
    intercourse with a new male partner that I have been dating for a couple of weeks.”

    Name 2 types of intercourse are at the highest
    risk for contracting HIV

    1. Unprotected vaginal sex

    2. Unprotected anal sex

    Why are women more susceptible to HIV in a
    male to female relationship (versus a male
    contracting it from a female)?

    In women, several factors can increase the risk
    of HIV transmission. For example, during
    vaginal or anal intercourse, women are at
    greater risk of acquiring HIV because
    receptive sex is generally riskier than insertive
    sex. Age-related thinning and dryness of the
    vaginal tissue—common in older women—
    can lead to microtears during intercourse,
    providing a pathway for HIV transmission.
    Biologically, women are more vulnerable to
    infection due to the larger mucosal surface
    area exposed during penile penetration.
    Additionally, young women under the age of
    17 are at even higher risk because they have
    an underdeveloped cervix and produce less
    protective vaginal mucus.

    HPI:

    Lisa is a 19 year ld female G0P0 who presents with a one week history of abnormal discharge
    after having unprotected vaginal intercourse with a new male partner.

    • Onset: one week
    • Locating: vaginal
    • Duration: ongoing
    • Characteristic: abnormal
    • Aggrevating/relieving factors: none stated
    • Treatment: none tried

    HPI questions:

    • Is there any vaginal itching, burning or odor?
    • Are you having any symptoms such as cramping, pelvic pain, fever, burning when you pee?
    • Have you had this type of discharge in the past?
    • When was the last time you were tested for STIs?

    Gyn history:

    • LMP: 2 weeks ago, stated, regular
    • Unknown if on birth control at this time
    • Sexually active, new male partner, no protection
    • No known gynocological issues at this time.

    Medical history

    • No known medical conditions
    • No known surgical conditions
    • No known drug allergies
    • Immunizations: up to date

    Family history:

    • Mother: no known medical history
    • Father: no known medical history
    • Maternal grandmother: no known medical history
    • Paternal grandmother: no known medical history,

    Social history

    • Goes to school

    • Balanced diet
    • Regular exercise
    • No drug or alcohol use
    • Sexual history: one new male partner, no protection
    • Relationship: new

    Other questions

    • Are you in a monogamous relationship?
    • Do you practice safe sex?

    Review of systems:

    • General: healthy, denies fever denies chills
    • Neuro: denies headacces or dizziness
    • Cardiovascular: denies chest pain or palpitations
    • Resp: denies shortness of breaeth or cough
    • GI: denies nausea, vomiting or diarrhea or abdominal pain
    • GU: positive abnormal discharge
    • Skin: denies rash, denies new lesions
    • Health maintenance: No Pap in the last 12 months due to age

    Objective

    Vitals: WNL

    • Temp: 98.6
    • BP: 120/80
    • HR:78
    • RR: 17
    • Heihgt: 5’4”
    • Weight: 135
    • BMI: 23.2

    Physical exam:

    • General: AAOx4, no acute distress
    • abdomen soft, non tender
    • Pelvic:

    o Vulva: normal appearance
    o Vagina: abnormal discharge
    o Cervix: normal
    o Uterus: non tender
    o Adnexa: no masses or tenderness

    POCT

    • Urine pregnancy : negative
    o Rule out pregnancy due to age and no condom use
    • Wet mount with KOH and send out check for chlamydia, gonorrhea, BV, trichomonas
    o KOH to help identify yeast, or bv or trichomonas cells
    • NAAT
    o For STI screening

    Assessment

    Final diagnosis:

    • Vaginal candidiasis B37.3 – clinical presentation of abnormal discharge

    Differential:

    • Bacterial vaginosis N76.0 – due to new sexual partner after unprotected sex
    • Trichomoniasis A59.9 – due to new sexual partner after unprotected sex
    • Chlamydia A56.0 – due to new sexual partner after unprotected sex

    Plan

    Diagnostics:

    • NAAT: Chlamydia, Gonorrhea and trichomonas
    • KOH for BV
    • Serology for HIV, syphilis, Hep B and C
    • Pap smear

    Treatments:

    • Fluconazole 150 mg Po x 1 dose orally

    o This medication is being prescribed at tis time as it is the first line therapy for uncomplicated
    candidiasis, some of the side effects are GI upset, and elevated liver enzymes. This
    medication should not be prescribed if patient has a history of liver disease.

    If STI positive: depending on what STI patient comes back positive for, prescriptions will
    change. Both patient and partner will need to be treated and abstain from sex for a week.

    Patient education:

    • Risk factors for STIs
    • Abstain from sex for 7 days until symptoms have resolved, and medication taken
    • Practice safe sex
    • Refrain from having multiple partners as it can place you at higher risks for HIV andSTIs
    • Routine STI screening

    Complications: if untrearted can causes recurect yeast infectons, risk of spreading infection to
    partner and increased risk for HIV and other STIs.

    Referals: refer to GYN follow up

    Follow up;

    • Office will call when lab results return
    • Follow up in one week if symptoms do not improve
    • Pap smear

    Health maintenance:

    • Pap smear starting at age 21
    • Hpv vaccine
    • STI screening annualy or whena new partner
    • Up to date on vaccines

  • [Solved] week 2 DB response

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    see attachment – a year ago **files (1)** – ## Week2DBresponse–.pdf **## Week2DBresponse–.pdf** Infe ctio n Description Presentation Causes/Risk Factors Treatment per CDC Additional Info Can dida Fungal infection (yeast) Vulvar itching, thick white discharge Antibiotics use, diabetes, pregnancy, t…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    see attachment

    – a year ago

    **files (1)**

    – ## Week2DBresponse–.pdf

    **## Week2DBresponse–.pdf**

    Infe
    ctio
    n

    Description Presentation
    Causes/Risk

    Factors
    Treatment per

    CDC Additional Info

    Can
    dida

    Fungal
    infection
    (yeast)

    Vulvar
    itching, thick
    white
    discharge

    Antibiotics use,
    diabetes,
    pregnancy, tight
    clothes

    Fluconazole
    150 mg PO
    single dose

    Not sexually
    transmitted

    BV
    Bacterial
    vaginosis

    Thin gray
    discharge,
    fishy odor

    Douching,
    multiple partners,
    new sex partner

    Metronidazole
    500 mg PO
    BID x 7 days

    Not an STI, but
    related to sexual
    activity

    Chl
    amy
    dia

    Bacterial STI

    Often
    asymptomatic,
    discharge,
    dysuria

    Unprotected sex,
    <25 yrs, multiple
    partners

    Doxycycline
    100 mg BID x
    7 days

    Screen all
    sexually active
    females <25

    Gon
    orrh
    ea

    Bacterial STI
    Purulent
    discharge,
    pelvic pain

    Same as
    chlamydia

    Ceftriaxone
    500 mg IM +
    doxycycline

    Often co-infected
    with chlamydia

    Tric
    hom
    onas

    Protozoan
    STI

    Frothy
    yellow-green
    discharge,
    odor

    Unprotected sex,
    multiple partners

    Metronidazole
    2g PO single
    dose

    Treat both
    partners

    Cer
    vicit
    is

    Inflammation
    of cervix
    often due to
    STI

    Bleeding,
    discharge,
    pelvic pain

    Chlamydia,
    gonorrhea

    Treat based on
    causative
    organism

    Can lead to PID

    PID

    Infection of
    upper
    reproductive
    tract

    Pelvic pain,
    fever, cervical
    motion pain

    Untreated STIs
    Ceftriaxone +
    doxycycline +
    metronidazole

    Risk for
    infertility

    HIV

    Virus
    affecting
    immune
    system

    Fever, fatigue,
    weight loss

    Needle sharing,
    sex, mother-to-
    child

    Antiretroviral
    therapy (ART)

    Lifelong
    management

    Syp
    hilis

    Bacterial STI
    (Treponema
    pallidum)

    Chancre, rash,
    systemic
    symptoms

    Sexual contact
    with infected
    person

    Penicillin G
    benzathine IM

    Multiple stages;
    test with RPR/
    VDRL

    Table 2: STI Knowledge Questions

    SOAP Note – Tina, 27-year-old Female

    Subjective:

    Chief Complaint (CC):
    “My vagina is burning, and I have painful blisters.”

    HPI (OLDCARTS):

    Hep
    B

    Liver
    infection due
    to HBV

    Fatigue,
    jaundice,
    nausea

    Sexual contact,
    needle use

    Supportive,
    antivirals for
    chronic cases

    Vaccine available

    Hep
    C

    Liver
    infection due
    to HCV

    Often
    asymptomatic,
    may cause
    fatigue

    Blood-to-blood
    contact, needle
    sharing

    Direct-acting
    antivirals
    (DAAs)

    No vaccine;
    chronic if
    untreated

    HS
    V

    Herpes
    simplex virus
    (type 1 or 2)

    Painful
    vesicles/
    ulcers, fever

    Sexual contact
    Acyclovir,
    Valacyclovir

    Recurrent; no
    cure, only
    symptom
    management

    Question Answer

    Name 10 Risk Factors for
    contracting STIs and HIV

    Unprotected sex, multiple partners, new partner, age <25,
    MSM, history of STIs, drug use, sex work, inconsistent
    condom use, partner with STI

    Name 5 safer sex practices
    Use condoms, limit partners, regular testing, mutual
    monogamy, avoid sex under influence

    Can HIV be transmitted
    through sweat, saliva, and
    tears?

    No. HIV is not transmitted through sweat, saliva, or tears due
    to insufficient viral load

    Name 2 types of intercourse at
    highest risk for contracting
    HIV

    Anal sex (receptive), vaginal sex (receptive)

    Why are women more
    susceptible to HIV in male-to-
    female transmission?

    Larger mucosal surface area exposed, higher viral load in
    semen, potential microtears during sex

    • The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
    ago. The area of concern is in her left labia minora. The patient describes that blisters as
    painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
    and tight clothing worsen the pain. The patient describes relief with cool compresses, and
    loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
    6/10.

    Medical History:

    • no previous medical history

    • no known allergies to drugs, food, or environmental factors

    • no recent illnesses or hospitalizations

    • vaccinations are up to date

    Surgical History:

    • No prior surgical history

    Social History:

    • #2 sexual partners in the last 6–12 months

    • Use of protection (condoms)

    • Tobacco, alcohol, recreational drug use, x2 a month socially

    • sexual practices (oral, vaginal, anal)

    Medications:

    • Currently not on any medication

    Allergies:

    • NKDA (No Known Drug Allergies)

    Objective:

    Vital Signs:

    • Temp: 98.6°F

    • HR: 76 bpm

    • BP: 112/70

    • RR: 16/min

    • SpO₂: 98% RA

    Physical Exam:

    • Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
    labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
    No inguinal lymphadenopathy.

    • Other Systems: Normal

    Point of Care Testing (POCT):

    • HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
    2021)

    • HIV rapid test: Recommended for new STI evaluation

    • Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

    • Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

    Assessment/Diagnosis:

    Presumptive Diagnosis:

    • Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

    Rationale:

    • Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
    minora, recent unprotected sex, no previous known episodes.

    Differential Diagnoses:

    1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

    2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

    3. Syphilis (Primary): Typically a painless chancre; not vesicular.

    Plan:

    Pharmacologic Treatment (Assuming HSV PCR Positive):

    • Acyclovir 400 mg tablet PO TID for 10 days

    Patient Education:

    • Medication Use: Take all medication as prescribed, even if symptoms improve early.

    • Side Effects: May include nausea, headache, dizziness.

    • Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
    even when asymptomatic.

    • Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

    • Partner Notification: Partners should be informed and may need testing.

    • Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
    year).

    Non-Pharmacologic Management:

    • Keep area clean and dry.

    • Use sitz baths and loose clothing.

    • Apply cool compresses to soothe discomfort.

    Follow-Up:

    • Return to clinic in 1–2 weeks or sooner if symptoms worsen.

    • Retesting or management for other STI test results as they return.

    Complications of Non-Treatment:

    • Increased risk of HIV transmission

    • Severe and prolonged outbreaks, especially in immunocompromised patients

    • Psychological distress

    • Neonatal HSV transmission risk in future pregnancies

    – Table 2: STI Knowledge Questions
    – SOAP Note – Tina, 27-year-old Female
    – Subjective:
    – Objective:
    – Assessment/Diagnosis:
    – Plan:
    – Pharmacologic Treatment (Assuming HSV PCR Positive):
    – Patient Education:
    – Non-Pharmacologic Management:
    – Follow-Up:
    – Complications of Non-Treatment:

    **## Week2DBresponse–.pdf**

    Infe
    ctio
    n

    Description Presentation
    Causes/Risk

    Factors
    Treatment per

    CDC Additional Info

    Can
    dida

    Fungal
    infection
    (yeast)

    Vulvar
    itching, thick
    white
    discharge

    Antibiotics use,
    diabetes,
    pregnancy, tight
    clothes

    Fluconazole
    150 mg PO
    single dose

    Not sexually
    transmitted

    BV
    Bacterial
    vaginosis

    Thin gray
    discharge,
    fishy odor

    Douching,
    multiple partners,
    new sex partner

    Metronidazole
    500 mg PO
    BID x 7 days

    Not an STI, but
    related to sexual
    activity

    Chl
    amy
    dia

    Bacterial STI

    Often
    asymptomatic,
    discharge,
    dysuria

    Unprotected sex,
    <25 yrs, multiple
    partners

    Doxycycline
    100 mg BID x
    7 days

    Screen all
    sexually active
    females <25

    Gon
    orrh
    ea

    Bacterial STI
    Purulent
    discharge,
    pelvic pain

    Same as
    chlamydia

    Ceftriaxone
    500 mg IM +
    doxycycline

    Often co-infected
    with chlamydia

    Tric
    hom
    onas

    Protozoan
    STI

    Frothy
    yellow-green
    discharge,
    odor

    Unprotected sex,
    multiple partners

    Metronidazole
    2g PO single
    dose

    Treat both
    partners

    Cer
    vicit
    is

    Inflammation
    of cervix
    often due to
    STI

    Bleeding,
    discharge,
    pelvic pain

    Chlamydia,
    gonorrhea

    Treat based on
    causative
    organism

    Can lead to PID

    PID

    Infection of
    upper
    reproductive
    tract

    Pelvic pain,
    fever, cervical
    motion pain

    Untreated STIs
    Ceftriaxone +
    doxycycline +
    metronidazole

    Risk for
    infertility

    HIV

    Virus
    affecting
    immune
    system

    Fever, fatigue,
    weight loss

    Needle sharing,
    sex, mother-to-
    child

    Antiretroviral
    therapy (ART)

    Lifelong
    management

    Syp
    hilis

    Bacterial STI
    (Treponema
    pallidum)

    Chancre, rash,
    systemic
    symptoms

    Sexual contact
    with infected
    person

    Penicillin G
    benzathine IM

    Multiple stages;
    test with RPR/
    VDRL

    Table 2: STI Knowledge Questions

    SOAP Note – Tina, 27-year-old Female

    Subjective:

    Chief Complaint (CC):
    “My vagina is burning, and I have painful blisters.”

    HPI (OLDCARTS):

    Hep
    B

    Liver
    infection due
    to HBV

    Fatigue,
    jaundice,
    nausea

    Sexual contact,
    needle use

    Supportive,
    antivirals for
    chronic cases

    Vaccine available

    Hep
    C

    Liver
    infection due
    to HCV

    Often
    asymptomatic,
    may cause
    fatigue

    Blood-to-blood
    contact, needle
    sharing

    Direct-acting
    antivirals
    (DAAs)

    No vaccine;
    chronic if
    untreated

    HS
    V

    Herpes
    simplex virus
    (type 1 or 2)

    Painful
    vesicles/
    ulcers, fever

    Sexual contact
    Acyclovir,
    Valacyclovir

    Recurrent; no
    cure, only
    symptom
    management

    Question Answer

    Name 10 Risk Factors for
    contracting STIs and HIV

    Unprotected sex, multiple partners, new partner, age <25,
    MSM, history of STIs, drug use, sex work, inconsistent
    condom use, partner with STI

    Name 5 safer sex practices
    Use condoms, limit partners, regular testing, mutual
    monogamy, avoid sex under influence

    Can HIV be transmitted
    through sweat, saliva, and
    tears?

    No. HIV is not transmitted through sweat, saliva, or tears due
    to insufficient viral load

    Name 2 types of intercourse at
    highest risk for contracting
    HIV

    Anal sex (receptive), vaginal sex (receptive)

    Why are women more
    susceptible to HIV in male-to-
    female transmission?

    Larger mucosal surface area exposed, higher viral load in
    semen, potential microtears during sex

    • The patient presented with a C/C of vaginal burning and painful blisters that began 3 days
    ago. The area of concern is in her left labia minora. The patient describes that blisters as
    painful and having a burning sensation with visible fluid-filled vesicles. Friction, urination,
    and tight clothing worsen the pain. The patient describes relief with cool compresses, and
    loose clothing. The discomfort is constant with intermittent sharp pain. She rates the pain a
    6/10.

    Medical History:

    • no previous medical history

    • no known allergies to drugs, food, or environmental factors

    • no recent illnesses or hospitalizations

    • vaccinations are up to date

    Surgical History:

    • No prior surgical history

    Social History:

    • #2 sexual partners in the last 6–12 months

    • Use of protection (condoms)

    • Tobacco, alcohol, recreational drug use, x2 a month socially

    • sexual practices (oral, vaginal, anal)

    Medications:

    • Currently not on any medication

    Allergies:

    • NKDA (No Known Drug Allergies)

    Objective:

    Vital Signs:

    • Temp: 98.6°F

    • HR: 76 bpm

    • BP: 112/70

    • RR: 16/min

    • SpO₂: 98% RA

    Physical Exam:

    • Genital Exam: Multiple small grouped vesicles on an erythematous base noted on the left
    labia minora, tender to palpation. No foul-smelling discharge. No cervical motion tenderness.
    No inguinal lymphadenopathy.

    • Other Systems: Normal

    Point of Care Testing (POCT):

    • HSV PCR swab from lesion: High sensitivity and specificity for HSV-1 and HSV-2 (CDC,
    2021)

    • HIV rapid test: Recommended for new STI evaluation

    • Urine NAAT for gonorrhea and chlamydia: Evaluate for co-infections

    • Syphilis RPR and Hepatitis B/C screening: Per CDC recommendations for STI screening

    Assessment/Diagnosis:

    Presumptive Diagnosis:

    • Genital Herpes Simplex Virus (HSV) Infection – ICD-10: A60.9

    Rationale:

    • Classic presentation of painful, fluid-filled vesicles on erythematous base, localized on labia
    minora, recent unprotected sex, no previous known episodes.

    Differential Diagnoses:

    1. Contact Dermatitis: Less likely—symptoms typically bilateral and not vesicular.

    2. Chancroid: Rare in the U.S.; painful ulcers with ragged borders, not grouped vesicles.

    3. Syphilis (Primary): Typically a painless chancre; not vesicular.

    Plan:

    Pharmacologic Treatment (Assuming HSV PCR Positive):

    • Acyclovir 400 mg tablet PO TID for 10 days

    Patient Education:

    • Medication Use: Take all medication as prescribed, even if symptoms improve early.

    • Side Effects: May include nausea, headache, dizziness.

    • Transmission: Avoid sexual activity until lesions are fully healed. HSV can be transmitted
    even when asymptomatic.

    • Safe Sex: Use condoms consistently to reduce recurrence transmission risk.

    • Partner Notification: Partners should be informed and may need testing.

    • Chronic Management: Discuss suppressive therapy if recurrences occur frequently (>6/
    year).

    Non-Pharmacologic Management:

    • Keep area clean and dry.

    • Use sitz baths and loose clothing.

    • Apply cool compresses to soothe discomfort.

    Follow-Up:

    • Return to clinic in 1–2 weeks or sooner if symptoms worsen.

    • Retesting or management for other STI test results as they return.

    Complications of Non-Treatment:

    • Increased risk of HIV transmission

    • Severe and prolonged outbreaks, especially in immunocompromised patients

    • Psychological distress

    • Neonatal HSV transmission risk in future pregnancies

    – Table 2: STI Knowledge Questions
    – SOAP Note – Tina, 27-year-old Female
    – Subjective:
    – Objective:
    – Assessment/Diagnosis:
    – Plan:
    – Pharmacologic Treatment (Assuming HSV PCR Positive):
    – Patient Education:
    – Non-Pharmacologic Management:
    – Follow-Up:
    – Complications of Non-Treatment:

  • [Solved] BEHS495 WEEK 1 POST HELP

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    HELP ASAP – a year ago **files (3)** – ## BEHS495WEEK1DISCUSSION.docx – ## BEHS495WEEK1LEARNINGRESOURCES.docx – Week1ChicagoJournals.pdf **## BEHS495WEEK1DISCUSSION.docx** BEHS495 WEEK 1 DISCUSSION Discussion 1 – Week 1: Interdisciplinarity Revisited Must post first. Subscribe ![](https://www.sweets…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    HELP ASAP

    – a year ago

    **files (3)**

    – ## BEHS495WEEK1DISCUSSION.docx

    – ## BEHS495WEEK1LEARNINGRESOURCES.docx

    – Week1ChicagoJournals.pdf

    **## BEHS495WEEK1DISCUSSION.docx**

    BEHS495 WEEK 1 DISCUSSION

    Discussion 1 – Week 1: Interdisciplinarity Revisited

    Must post first.

    Subscribe

    ![](https://www.sweetstudy.com/questions/behs495-week-1-post-help-20915233)

    Discussion Question: You have chosen a major that is interdisciplinary in nature. For this discussion topic, respond to the following questions:

    1. In your own words, what does it mean to be a "social scientist?"

    2.  What is the distinction between "multidisciplinary" and "interdisciplinary"?

    3. Why interdisciplinarity?  What are the advantages?  Are there any downfalls?

    Please support your arguments using sources from any of your previous BEHS courses or empirical sources from the library.  (Don't worry if you haven't held onto your previous texts from other courses. Library sources will suffice.)   This is a key aspect of this conference posting — Because this is a Capstone course, it requires you to draw on the things you have learned and resources from your previous courses to answer these questions.

    When writing your posts, it is very important that you focus not just on summary but also on analysis. These posts are how I determine your mastery of the material and your critical thinking. Remember:

    · Make sure you start your initial post as a New Thread in the LEO Discussion board, or I might not find it when I grade.

    · Your first paragraph needs to be an introduction to your post.

    · Your final paragraph should be a conclusion which pulls your ideas together.

    · Your middle paragraphs should discuss your arguments.

    · All posts need to be written in APA style and cite resources. You are encouraged to draw on resources from your courses across your entire major. There is not a lot of new information learned in this course, as I want to see you bringing together all of what you have learned at UMGC.

    · Please check your post against the Guide for Good Writing before you submit it, as points will be deducted if you make those common writing errors. (This document is located in the Writing Resources module.)

    _Provide your initial post by 11:59 pm on Sunday. Please copy and paste the discussion prompts into your post so that it is clear what you are answering where in your post. Place your answers to each question directly below the question. Please use in-text APA citations (with DOI numbers!) within your post as well as full APA references at the end of your post.  Please write in paragraph form and not bulleted form per strong writing scholarly writing requirements. Your initial post should be at least 250 words in length, but many students end up writing more to fully address the questions and provide support from references._

    ## image1.jpeg

    **## BEHS495WEEK1LEARNINGRESOURCES.docx**

    BEHS495 WEEK 1 LEARNING RESOURCES

    [https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520](https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520)

    [https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im](https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im)

    [http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site](http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site)

    [https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520)

    **Week1ChicagoJournals.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/week1chicagojournals-pdf)

    **Week1ChicagoJournals.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/week1chicagojournals-pdf)

    **## BEHS495WEEK1DISCUSSION.docx**

    BEHS495 WEEK 1 DISCUSSION

    Discussion 1 – Week 1: Interdisciplinarity Revisited

    Must post first.

    Subscribe

    ![](https://www.sweetstudy.com/questions/behs495-week-1-post-help-20915233)

    Discussion Question: You have chosen a major that is interdisciplinary in nature. For this discussion topic, respond to the following questions:

    1. In your own words, what does it mean to be a "social scientist?"

    2.  What is the distinction between "multidisciplinary" and "interdisciplinary"?

    3. Why interdisciplinarity?  What are the advantages?  Are there any downfalls?

    Please support your arguments using sources from any of your previous BEHS courses or empirical sources from the library.  (Don't worry if you haven't held onto your previous texts from other courses. Library sources will suffice.)   This is a key aspect of this conference posting — Because this is a Capstone course, it requires you to draw on the things you have learned and resources from your previous courses to answer these questions.

    When writing your posts, it is very important that you focus not just on summary but also on analysis. These posts are how I determine your mastery of the material and your critical thinking. Remember:

    · Make sure you start your initial post as a New Thread in the LEO Discussion board, or I might not find it when I grade.

    · Your first paragraph needs to be an introduction to your post.

    · Your final paragraph should be a conclusion which pulls your ideas together.

    · Your middle paragraphs should discuss your arguments.

    · All posts need to be written in APA style and cite resources. You are encouraged to draw on resources from your courses across your entire major. There is not a lot of new information learned in this course, as I want to see you bringing together all of what you have learned at UMGC.

    · Please check your post against the Guide for Good Writing before you submit it, as points will be deducted if you make those common writing errors. (This document is located in the Writing Resources module.)

    _Provide your initial post by 11:59 pm on Sunday. Please copy and paste the discussion prompts into your post so that it is clear what you are answering where in your post. Place your answers to each question directly below the question. Please use in-text APA citations (with DOI numbers!) within your post as well as full APA references at the end of your post.  Please write in paragraph form and not bulleted form per strong writing scholarly writing requirements. Your initial post should be at least 250 words in length, but many students end up writing more to fully address the questions and provide support from references._

    ## image1.jpeg

    **## BEHS495WEEK1LEARNINGRESOURCES.docx**

    BEHS495 WEEK 1 LEARNING RESOURCES

    [https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520](https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520)

    [https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im](https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im)

    [http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site](http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site)

    [https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520)

    **Week1ChicagoJournals.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/week1chicagojournals-pdf)

    **## BEHS495WEEK1DISCUSSION.docx**

    BEHS495 WEEK 1 DISCUSSION

    Discussion 1 – Week 1: Interdisciplinarity Revisited

    Must post first.

    Subscribe

    ![](https://www.sweetstudy.com/questions/behs495-week-1-post-help-20915233)

    Discussion Question: You have chosen a major that is interdisciplinary in nature. For this discussion topic, respond to the following questions:

    1. In your own words, what does it mean to be a "social scientist?"

    2.  What is the distinction between "multidisciplinary" and "interdisciplinary"?

    3. Why interdisciplinarity?  What are the advantages?  Are there any downfalls?

    Please support your arguments using sources from any of your previous BEHS courses or empirical sources from the library.  (Don't worry if you haven't held onto your previous texts from other courses. Library sources will suffice.)   This is a key aspect of this conference posting — Because this is a Capstone course, it requires you to draw on the things you have learned and resources from your previous courses to answer these questions.

    When writing your posts, it is very important that you focus not just on summary but also on analysis. These posts are how I determine your mastery of the material and your critical thinking. Remember:

    · Make sure you start your initial post as a New Thread in the LEO Discussion board, or I might not find it when I grade.

    · Your first paragraph needs to be an introduction to your post.

    · Your final paragraph should be a conclusion which pulls your ideas together.

    · Your middle paragraphs should discuss your arguments.

    · All posts need to be written in APA style and cite resources. You are encouraged to draw on resources from your courses across your entire major. There is not a lot of new information learned in this course, as I want to see you bringing together all of what you have learned at UMGC.

    · Please check your post against the Guide for Good Writing before you submit it, as points will be deducted if you make those common writing errors. (This document is located in the Writing Resources module.)

    _Provide your initial post by 11:59 pm on Sunday. Please copy and paste the discussion prompts into your post so that it is clear what you are answering where in your post. Place your answers to each question directly below the question. Please use in-text APA citations (with DOI numbers!) within your post as well as full APA references at the end of your post.  Please write in paragraph form and not bulleted form per strong writing scholarly writing requirements. Your initial post should be at least 250 words in length, but many students end up writing more to fully address the questions and provide support from references._

    ## image1.jpeg

    **## BEHS495WEEK1LEARNINGRESOURCES.docx**

    BEHS495 WEEK 1 LEARNING RESOURCES

    [https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520](https://leocontent.umgc.edu/content/dam/course-content/tus/behs/behs-495/document/Merton.pdf?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/cc10ab39-033d-4dd1-a62a-3ba9842fdf82.html?ou=1318520)

    [https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im](https://youtu.be/Y2hEiMOgc1g?si=tM-qk9l4awC1S7im)

    [http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site](http://ezproxy.umgc.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=heh&AN=94573924&site=ehost-live&scope=site)

    [https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/2047da3a-cab3-474c-bcf8-6d83e3c57124.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/ba3cdc3b-9181-4c74-9b8e-f3bdf92e425b.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/a5aa231a-ef65-4d89-a146-2db47d26ba3f.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/b37d1f86-8c74-447a-9b69-3cae6464b7c9.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/13a16678-00b2-4199-b54e-4143c79f8456.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/52142263-7ef3-4a06-94e8-4328bb845385.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/d59a4cdd-545e-4798-bc44-76dd51ecde64.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/6720e84f-0028-4d69-9a1d-a6a0bd9c32aa.html?ou=1318520)

    [https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520](https://leocontent.umgc.edu/content/dam/permalink/3f2376a5-049a-4a3b-a57c-57bc215b7708.html?ou=1318520)

    **Week1ChicagoJournals.pdf**

    This file is too large to display. [View in new window](https://www.sweetstudy.com/files/week1chicagojournals-pdf)

  • [Solved] M2

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    The future of mental health in order adults. – a year ago **files (1)** – ## IND101Milestone2Template.docx **## IND101Milestone2Template.docx** [Student Name] _Instructions: Replace the example wording in brackets below with your wording for each prompt._ **IND101 Milestone 2 Template** **Topic:**…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    The future of mental health in order adults.

    – a year ago

    **files (1)**

    – ## IND101Milestone2Template.docx

    **## IND101Milestone2Template.docx**

    [Student Name]

    _Instructions: Replace the example wording in brackets below with your wording for each prompt._

    **IND101 Milestone 2 Template**

    **Topic:**[Example: Climate Change]

    1.
    **List of narrowed ideas from the freewrite activity:**

    · [Examples: Warmer ocean temperatures

    · Melting ice caps

    · Greenhouse gases

    · Fossil fuels

    · Disagreement about whether climate change is real

    · How politicians talk about climate change

    · Electric cars

    · Policies to reduce cost of electric vehicles

    · Wind farms

    · Solar power

    · The cost of alternative energy

    · How the international community is addressing climate change

    · Global leaders in addressing climate change

    · How the US compares to other nations in addressing climate change]

    2.
    **Description with at least 4 underlined key terms or short phrases:**

    [Example description:
    Electric cars are an important step toward addressing
    climate change by reducing our reliance on
    gasoline. However, electric cars are still too
    expensive for the average American to buy, so the government should provide
    financial incentives to
    car companies to reduce the price for
    consumers and increase the availability of
    charging stations.]

    3.
    **At least 2 synonyms, abbreviations, or alternatives for each key term:**

    · [Examples: Electric cars: electric vehicles, plug-in, EV]

    · [Climate change: global warming, temperature change, environmental change]

    · [Gasoline: petroleum, fuel]

    · [Expensive: pricey, costly]

    · [Financial incentives: inducement, tax credit, government subsidy]

    · [Car companies: car manufacturers, automobile manufacturers (also: Tesla, Chevrolet, Ford, etc.)]

    · [Consumers: shopper, buyer]

    · [Charging stations: recharging hub, electric recharging point]

    4.
    **At least 5 Excelsior Library Sources**

    **Source 1:**

    ·
    **Title:**[Example:
    How China Beat the US in Electric Vehicle Manufacturing And why it’s time for the United States to get serious about industrial policies.]

    ·
    **Date:**[2021]

    ·
    **Author:**[Graham, J. D., Belton, K. B., & Suri, X.]

    ·
    **Permalink:**[
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site)]

    **Source 2:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 3:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 4:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 5:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Optional: Instead of bulleted source information above, try an APA style reference list (but make sure to still include a URL or Permalink to each source):**

    [Examples:

    Dua, R., & White, K. (2020). Understanding latent demand for hybrid and plug-in electric vehicles using large-scale longitudinal survey data of US new vehicle buyers.
    _Energy Efficiency_,
    _13_(6), 1063–1074.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=145259635&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=145259635&site=eds-live&scope=site)

    Graham, J. D., Belton, K. B., & Suri, X. (2021). How China beat the US in electric vehicle manufacturing and why it’s time for the United States to get serious about industrial policies.
    _Issues in Science & Technology_,
    _37_(2), 72–79.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site)

    National Research Council (U.S.). (2015).
    _Overcoming barriers to deployment of plug-in electric_ _vehicles_. National Academies Press.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1099383&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1099383&site=eds-live&scope=site)

    Noori, M., & Tatari, O. (2016). Development of an agent-based model for regional market penetration projections of electric vehicles in the United States.
    _Energy_,
    _96_, 215–230.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0360544215016606&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0360544215016606&site=eds-live&scope=site)

    Sperling, D. (2018). Electric vehicles: Approaching the tipping point.
    _Bulletin of the Atomic_ _Scientists_,
    _74_(1), 11–18.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ulh&AN=127161734&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ulh&AN=127161734&site=eds-live&scope=site)]

    **## IND101Milestone2Template.docx**

    [Student Name]

    _Instructions: Replace the example wording in brackets below with your wording for each prompt._

    **IND101 Milestone 2 Template**

    **Topic:**[Example: Climate Change]

    1.
    **List of narrowed ideas from the freewrite activity:**

    · [Examples: Warmer ocean temperatures

    · Melting ice caps

    · Greenhouse gases

    · Fossil fuels

    · Disagreement about whether climate change is real

    · How politicians talk about climate change

    · Electric cars

    · Policies to reduce cost of electric vehicles

    · Wind farms

    · Solar power

    · The cost of alternative energy

    · How the international community is addressing climate change

    · Global leaders in addressing climate change

    · How the US compares to other nations in addressing climate change]

    2.
    **Description with at least 4 underlined key terms or short phrases:**

    [Example description:
    Electric cars are an important step toward addressing
    climate change by reducing our reliance on
    gasoline. However, electric cars are still too
    expensive for the average American to buy, so the government should provide
    financial incentives to
    car companies to reduce the price for
    consumers and increase the availability of
    charging stations.]

    3.
    **At least 2 synonyms, abbreviations, or alternatives for each key term:**

    · [Examples: Electric cars: electric vehicles, plug-in, EV]

    · [Climate change: global warming, temperature change, environmental change]

    · [Gasoline: petroleum, fuel]

    · [Expensive: pricey, costly]

    · [Financial incentives: inducement, tax credit, government subsidy]

    · [Car companies: car manufacturers, automobile manufacturers (also: Tesla, Chevrolet, Ford, etc.)]

    · [Consumers: shopper, buyer]

    · [Charging stations: recharging hub, electric recharging point]

    4.
    **At least 5 Excelsior Library Sources**

    **Source 1:**

    ·
    **Title:**[Example:
    How China Beat the US in Electric Vehicle Manufacturing And why it’s time for the United States to get serious about industrial policies.]

    ·
    **Date:**[2021]

    ·
    **Author:**[Graham, J. D., Belton, K. B., & Suri, X.]

    ·
    **Permalink:**[
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site)]

    **Source 2:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 3:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 4:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Source 5:**

    ·
    **Title:**

    ·
    **Date:**

    ·
    **Author:**

    ·
    **Permalink:**

    **Optional: Instead of bulleted source information above, try an APA style reference list (but make sure to still include a URL or Permalink to each source):**

    [Examples:

    Dua, R., & White, K. (2020). Understanding latent demand for hybrid and plug-in electric vehicles using large-scale longitudinal survey data of US new vehicle buyers.
    _Energy Efficiency_,
    _13_(6), 1063–1074.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=145259635&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=asn&AN=145259635&site=eds-live&scope=site)

    Graham, J. D., Belton, K. B., & Suri, X. (2021). How China beat the US in electric vehicle manufacturing and why it’s time for the United States to get serious about industrial policies.
    _Issues in Science & Technology_,
    _37_(2), 72–79.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=tfh&AN=149318105&site=eds-live&scope=site)

    National Research Council (U.S.). (2015).
    _Overcoming barriers to deployment of plug-in electric_ _vehicles_. National Academies Press.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1099383&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1099383&site=eds-live&scope=site)

    Noori, M., & Tatari, O. (2016). Development of an agent-based model for regional market penetration projections of electric vehicles in the United States.
    _Energy_,
    _96_, 215–230.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0360544215016606&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=edselp&AN=S0360544215016606&site=eds-live&scope=site)

    Sperling, D. (2018). Electric vehicles: Approaching the tipping point.
    _Bulletin of the Atomic_ _Scientists_,
    _74_(1), 11–18.
    [http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ulh&AN=127161734&site=eds-live&scope=site](http://vlib.excelsior.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=ulh&AN=127161734&site=eds-live&scope=site)]

  • [Solved] discussion

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    ## Red Bead Experiment Discussion ### Purpose This assignment is intended to help you learn to assess quality, safety, and information systems to improve patient outcomes. ### Action Items **Complete the following:** – Watch the videos about the [Red Bead Experiment.Links to an external site.](https…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    ## Red Bead Experiment Discussion

    ### Purpose

    This assignment is intended to help you learn to assess quality, safety, and information systems to improve patient outcomes.

    ### Action Items

    **Complete the following:**

    – Watch the videos about the [Red Bead Experiment.Links to an external site.](https://www.youtube.com/watch?v=oMb_UKYHvto "Link")![](https://franklin.instructure.com/images/play_overlay.png)

    ### Initial Response

    Your initial response should address all of the elements below, in depth and breadth.  A minimum of 350 words is expected in your initial response.  Citations and references are included, in correct APA format.

    **Answer the following discussion questions:**

    – What are some of the management techniques Dr. Berwick uses to try to improve employee performance?
    – Do you think these management techniques are effective? Why or why not?
    – If you were the head of the Red Bead Company, what would you do to try to improve quality?
    – Do you think the management style in the Red Bead Company has any similarities to the way health care is managed? Explain your thinking and give an example, if possible.

    – [\
    \
    redbead.docx](https://www.sweetstudy.com/files/redbead-docx "redbead.docx")

    – a year ago

  • [Solved] Replies

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    [>Operations Management homework help](https://www.sweetstudy.com/fields/business-finance-operations-management) Replies – a year ago **responses** NOT RATED Purchase the answer to view it ![blurred-text](https://www.sweetstudy.com/assets/images/blurred-text.c4cde9f021be0abed13ca77c3d6d43d3.png) – C…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    [>Operations Management homework help](https://www.sweetstudy.com/fields/business-finance-operations-management)

    Replies

    – a year ago

    **responses**

    NOT RATED

    Purchase the answer to view it

    ![blurred-text](https://www.sweetstudy.com/assets/images/blurred-text.c4cde9f021be0abed13ca77c3d6d43d3.png)

    –

    CuffreplytoCheldera.docx

    –

    CurtisReplytoJoseph.docx

    ![homework question](https://www.sweetstudy.com/assets/images/loader.e99f1ef323fecd089c1cdcaaadcd1f9b.gif)

    plagiarism checkPurchase $25

  • [Solved] Nursing Dnp Essentials

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    ### Formative Assessment How does the role of the DNP-prepared nurse compare to other non-nursing advanced practice healthcare providers in the clinical setting? 300 words ### Document Type/Template – Word Document – [\ \ Rubric.pdf](https://www.sweetstudy.com/files/rubric-pdf-10294197 "Rubric.pdf…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    ### Formative Assessment

    How does the role of the DNP-prepared nurse compare to other non-nursing advanced practice healthcare providers in the clinical setting? 300 words

    ### Document Type/Template

    – Word Document

    – [\
    \
    Rubric.pdf](https://www.sweetstudy.com/files/rubric-pdf-10294197 "Rubric.pdf")

    – a year ago

  • [Solved] psychology

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    – a year ago **files (1)** – ## OnlineSocialPsychologyExperiment1.docx **## OnlineSocialPsychologyExperiment1.docx** ## Online Social Psychology Experiment For this assignment, please access the following link and complete one of the many online social psychology experiments listed there: [https://w…

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    – a year ago

    **files (1)**

    – ## OnlineSocialPsychologyExperiment1.docx

    **## OnlineSocialPsychologyExperiment1.docx**

    ## Online Social Psychology Experiment

    For this assignment, please access the following link and complete one of the many online social psychology experiments listed there:

    [https://www.socialpsychology.org/expts.htm](https://www.socialpsychology.org/expts.htm)

    After you have completed the experiment, please answer the following questions:

    1) What was the title of your experiment? What was the experiment about (in two sentences)?

    2) What were the research questions?

    3) What are the independent and dependent variables?

    4) What method(s) did the experimenter use? What did you do for the experiment? In other words, what was the procedure?

    5) What results do you think the experimenter might receive?

    **## OnlineSocialPsychologyExperiment1.docx**

    ## Online Social Psychology Experiment

    For this assignment, please access the following link and complete one of the many online social psychology experiments listed there:

    [https://www.socialpsychology.org/expts.htm](https://www.socialpsychology.org/expts.htm)

    After you have completed the experiment, please answer the following questions:

    1) What was the title of your experiment? What was the experiment about (in two sentences)?

    2) What were the research questions?

    3) What are the independent and dependent variables?

    4) What method(s) did the experimenter use? What did you do for the experiment? In other words, what was the procedure?

    5) What results do you think the experimenter might receive?

  • [Solved] week 2.1

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    discussion response – a year ago

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    discussion response

    – a year ago

  • [Solved] Sociology

    ✓ Verified Academic Solution Available

    Executive Solution Overview

    [>Sociology homework help](https://www.sweetstudy.com/fields/social-science-sociology) – a year ago **files (1)** – ## ASSIGNMENT.pptx **## ASSIGNMENT.pptx** Assignment Instructions STEPS View the "notes" section beneath each slide to view instructions. You can click on “Notes” at the bottom of the …

    Instant Solution Download

    $6.99

    Immediate access to the full model answer, formatted citations, and rubric breakdown.

    Need a Fresh Custom Paper?

    Have this question answered from scratch according to your specific instructions and deadline.

    Order on TutorsGallery →

    Assignment Prompt & Instructions

    [>Sociology homework help](https://www.sweetstudy.com/fields/social-science-sociology)

    – a year ago

    **files (1)**

    – ## ASSIGNMENT.pptx

    **## ASSIGNMENT.pptx**

    Assignment Instructions

    STEPS

    View the "notes" section beneath each slide to view instructions.

    You can click on “Notes” at the bottom of the slide, or select “View” from the main menu, then select “Notes.”

    You may need to drag the notes bar up to see more text.

    Notes Bar

    Drag the bar up to see notes

    This is the notes section!

    1

    Insert Name

    My Goals, Motivations, & Values

    Insert your name on this slide.

    Throughout the slide deck, add images and/or a background; adjust the font and color if you'd like. You can go to the "Design" tab and see a multitude of design options. If you'd like to get really fancy, you're welcome to add audio and/or video.

    Take a look at the rubric so you understand what is being assessed for your grade.

    2

    VALUES

    VALUES:

    After completing the values assessment in the Learning Resources, identify your top five values on the slide above. Add one image that relates to at least one of your identified values.

    3

    My SMART Goal Statements

    This is a section header. Add at least one design element (image and/or background).

    In next nine slides, you will create three SMART Goal Statements and identify your source(s) of motivation to achieve these goals.

    Academic Achievement

    Professional/Career Development

    Personal Growth

    4

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    ACADEMIC

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    5

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    6

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    7

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    PROFESSIONAL

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    8

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    9

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    10

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    PERSONAL

    GOAL PLANNER: What is the initial goal you have in mind?

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    11

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    12

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    13

    REFLECTION

    In the section above, write 3-5 thoughtful sentences about what you learned about yourself as you identified your values, motivations, and set your SMART goals.

    14

    ## image1.png

    **## ASSIGNMENT.pptx**

    Assignment Instructions

    STEPS

    View the "notes" section beneath each slide to view instructions.

    You can click on “Notes” at the bottom of the slide, or select “View” from the main menu, then select “Notes.”

    You may need to drag the notes bar up to see more text.

    Notes Bar

    Drag the bar up to see notes

    This is the notes section!

    1

    Insert Name

    My Goals, Motivations, & Values

    Insert your name on this slide.

    Throughout the slide deck, add images and/or a background; adjust the font and color if you'd like. You can go to the "Design" tab and see a multitude of design options. If you'd like to get really fancy, you're welcome to add audio and/or video.

    Take a look at the rubric so you understand what is being assessed for your grade.

    2

    VALUES

    VALUES:

    After completing the values assessment in the Learning Resources, identify your top five values on the slide above. Add one image that relates to at least one of your identified values.

    3

    My SMART Goal Statements

    This is a section header. Add at least one design element (image and/or background).

    In next nine slides, you will create three SMART Goal Statements and identify your source(s) of motivation to achieve these goals.

    Academic Achievement

    Professional/Career Development

    Personal Growth

    4

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    ACADEMIC

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    5

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    6

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    7

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    PROFESSIONAL

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    8

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    9

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    10

    SMART GOAL STATEMENT:

    | | |
    | — | — |
    | Criteria | Response |
    | S | |
    | M | |
    | A | |
    | R | |
    | T | |

    PERSONAL

    GOAL PLANNER: What is the initial goal you have in mind?

    S (SPECIFIC): What do you want to accomplish?

    M (MEASURABLE): How can you measure your progress? When will you know that you have achieved your goal?

    A (ACHIEVABLE): Do you have the skills and resources needed to achieve this goal? If not, how will you obtain them? Is this goal realistic in the timeframe you have established?

    R (RELEVANT): Why are you setting this goal now? Why does it matter?

    T (TIME-BOUND): When will you achieve this goal? State a specific timeframe!

    Once you have answered all the questions above, write out your SMART goal in the slide.

    11

    ACTION ITEMS

    List at least THREE actions that you will take to achieve this goal. Focus on specific actions (example: Block off time every Sunday night to plan my study schedule for the week) instead of attitudes or aspirations (example: work harder than I ever have to get good grades).

    12

    MOTIVATION

    MOTIVATION:

    Why do you want to achieve this goal? What or who inspires you to achieve this goal? Provide a short summary of your motivations.

    Include at least one powerful image OR provide a link to a (non-explicit) song that is representative of your "WHY" — your source of motivation. You can also provide both, if you'd like.

    13

    REFLECTION

    In the section above, write 3-5 thoughtful sentences about what you learned about yourself as you identified your values, motivations, and set your SMART goals.

    14

    ## image1.png